Treace Medical Concepts, Inc. (TMCI) |
|
25.19 -0.53 (-2.06%)
|
03-31 16:00 |
|
Open: |
25.9 |
Pre. Close: |
25.72 |
|
High:
|
25.905 |
Low:
|
25 |
|
Volume:
|
500,556 |
Market Cap:
|
1,541(M) |
|
|
|
Technical analysis |
as of: 2023-03-31 4:22:37 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 30.47 One year: 35.59 |
| Support: |
Support1: 22.05 Support2: 19.54 |
| Resistance: |
Resistance1: 26.09 Resistance2: 30.47 |
| Pivot: |
24.18  |
| Moving Average: |
MA(5): 25.27 MA(20): 23.83
MA(100): 23.3 MA(250): 20.63 |
| MACD: |
MACD(12,26): 0.7 Signal(9): 0.5 |
| Stochastic oscillator: |
%K(14,3): 83.1 %D(3): 82.1 |
| RSI: |
RSI(14): 61.2 |
| 52-week: |
High: 26.5 Low: 12.47 |
| Average Vol(K): |
3-Month: 418 (K) 10-Days: 333 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ TMCI ] has closed below upper band by 22.0%. Bollinger Bands are 14.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
25.93 - 26.06 |
26.06 - 26.14 |
|
Low:
|
24.69 - 24.86 |
24.86 - 24.97 |
|
Close:
|
24.94 - 25.2 |
25.2 - 25.37 |
|
Company Description |
|
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida. |
Headline News |
Wed, 29 Mar 2023
Treace Shareholder Action Reminder - Treace Medical Concepts ... - Benzinga
Tue, 14 Mar 2023
'Dodged a bullet': How fall of SVB is affecting First Coast companies - The Business Journals
Thu, 09 Mar 2023
Shareholders might want to keep a close eye on Treace Medical Concepts, Inc. (NASDAQ:TMCI) after insiders sold US$4.9m stock earlier this year - Simply Wall St
Wed, 08 Mar 2023
Treace Medical Concepts Inc Up 19.77% To $24.23 After Earnings Beat - InvestorsObserver
Wed, 08 Mar 2023
Form 10-K TREACE MEDICAL CONCEPTS, For: Dec 31 - StreetInsider.com
Wed, 08 Mar 2023
Health Care Sector Update for 03/08/2023: LFST, TMCI, MESO, XLV ... - Nasdaq
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
56 (M) |
| Shares Float |
34 (M) |
|
% Held by Insiders
|
38.8 (%) |
|
% Held by Institutions
|
49 (%) |
|
Shares Short
|
1,820 (K) |
|
Shares Short P.Month
|
1,970 (K) |
Stock Financials |
|
EPS
|
-0.35 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
1.85 |
|
Profit Margin (%)
|
-35.9 |
|
Operating Margin (%)
|
-29.5 |
|
Return on Assets (ttm)
|
-15.8 |
|
Return on Equity (ttm)
|
-56.5 |
|
Qtrly Rev. Growth
|
52.9 |
|
Gross Profit (p.s.)
|
1.37 |
|
Sales Per Share
|
2.26 |
|
EBITDA (p.s.)
|
-0.64 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-29 (M) |
|
Levered Free Cash Flow
|
-32 (M) |
Stock Valuations |
|
PE Ratio
|
-74.09 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
13.61 |
|
Price to Sales
|
11.13 |
|
Price to Cash Flow
|
-48.15 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
